Ruling in FDA v. Alliance for Hippocratic Medicine, on June 13, 2024, the majority opinion declared that “Under Article III of the Constitution, a plaintiff’s desire to make a drug less available for others does not establish standing to sue. Nor do the plaintiffs’ other standing theories suffice. Therefore, the plaintiffs lack standing to challenge FDA’s actions.”
The question presented was:
“[W]hether the plaintiffs have standing to sue under Article III of the Constitution.”
The opinion
Read the full rulingPDF · 505.02 KBPublished by the Supreme Court.
Oral argument
the Supreme Court recording · 42.6 MBArgument page →
